-
Nat Commun: Short-chain fatty acids may weaken the immunotherapy effect of CTLA-4 tumors.
Time of Update: 2020-10-20
Short-chain fatty acids are one of the important metabolites of gut microorganisms, and as signaling molecules affect a series of host activities. short-chain fatty acids (short-chain fatty acids, SCFA), also known as volatile fatty acids
-
News : Representatives of the Chinese nutrition community attended the 13th Asian Nutrition Conference.
Time of Update: 2020-10-20
teams to participate in the conference, during which more than 190 Chinese representatives participated in the meeting, on their respective research areas to carry out oral report exchange more than 130 times, wall newspaper exchange 40
-
NAT COMMUN: No. 1 CRISPR technology targets cancer cells in the body.
Time of Update: 2020-10-20
recently, based on CRISPR/Cas9 technology, researchers designed a simple, efficient, non-patient-specific gene editing strategy that allows specific and powerful destruction of FO in cancer cells by targeting two inclusions of genes involved in rearm.
-
The 2nd National Community Nutrition and Health Management Conference of the Community Nutrition
Time of Update: 2020-10-20
13-15, 2018, the 2nd National Conference on Community Nutrition and Health Management, sponsored by the Community Nutrition and Health Management Branch of the Chinese Nutrition Society, was held in Wuxi. Seeding on-site conference
-
The rural medical community health line project was launched in Guermu City, Qinghai Province.
Time of Update: 2020-10-20
Shouyuan of Tanggurangshan Township, a team of experts in public health nutrition at Qinghai University School of Medicine, and representatives of the Ed Foundation attended the launch ceremony. Tangula Mountain Town is located in the core area
-
Treating community-approved pneumonia the first new antibiotic in nearly 20 years has been approved by the European Union.
Time of Update: 2020-10-20
On July 28, local time, Nabriva Therapeutics announced that the European Commission (EC) had officially approved its innovative antibiotic Xenleta (lefamulin) for adult patients with community-acquired pneumonia (CAP).
-
EClinical Media: Toad monoantine therapy increases the risk of death in patients with COVID-19 sepsis.
Time of Update: 2020-10-20
findings may have some guiding significance for the treatment of the disease and may facilitate the design of new clinical trials for patients with COVID-19 severe illnesses.
-
NAT COMMUN: Tsinghua University and Huazhong University of Science and Technology jointly developed the new crown AI diagnostic tool.
Time of Update: 2020-10-19
In such a difficult multi-category diagnostic task, the researchers developed 97.81 percent AAUC for deep reel neural networks on 3,199 scans in the test queue, 92.99 percent for CC-CCII and 93.25 percent for two public data sets, MossMedData.
-
Blue Canhui: Building a "Community of Nutritional Destiny" with Probiotics
Time of Update: 2020-10-19
